Improving participation and diversity in gynecologic cancer trials
Official title: Enhancing accrual and diversity across gynecologic and solid tumor trials
Funded at University of Virginia · NIH-10777158 · Data updated 2026-11-12
This study is working to make it easier for women with gynecologic cancers to join clinical trials, so they can access new and better treatments by finding and fixing the obstacles that keep patients and doctors from participating.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $135,573 |
| NIH project number | 1R50CA285360-01 |
| Project ID | NIH-10777158 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women diagnosed with gynecologic malignancies who are seeking treatment options through clinical trials.
✕Less likely to help
Patients with non-gynecologic cancers or those not interested in participating in clinical trials may not benefit from this research.
What this research studies
This research aims to enhance the recruitment and diversity of participants in clinical trials focused on gynecologic cancers. The approach involves identifying and addressing barriers that prevent patients and providers from participating in these trials. The Principal Investigator, who is both a practicing Gynecologic Oncologist and a clinical researcher, will leverage their unique position to foster collaborations and mentorships that promote new clinical trial initiatives. By building a robust clinical research infrastructure, the project seeks to improve access to innovative treatments for women with gynecologic malignancies.
Why it matters
Potential benefit: If successful, this research could lead to more inclusive and effective clinical trials, ultimately improving treatment options for women with gynecologic cancers.
How similar studies have gone: Previous research has shown that targeted efforts to enhance diversity and participation in clinical trials can lead to improved patient outcomes and more representative data.
Where this research is happening
-
University of Virginia
Charlottesville, United States Active
Researchers
- Principal investigator: Duska, Linda — University of Virginia
- Study coordinator: Duska, Linda
Related research
Other NIH-funded projects on the same topics.
-
Dual-targeted DOTA CAR T cells with image-guided monitoring for solid tumors
A Penn team is developing a controllable CAR T cell therapy for solid tumors that can be tracked with PET imaging and guided by targeted agents to improve safety and effectiveness.
-
Improving patient access to gynecologic cancer trials at UVA
This grant helps UVA boost enrollment in gynecologic and solid tumor trials so more women with gynecologic cancers can access cutting-edge therapies.
-
Tuning CAR T cells to work better in solid tumors
A cancer-immunotherapy approach uses specially trained CAR T cells designed to attack solid tumors more effectively and safely.
-
A 3D lab tool to see how solid tumors squeeze and spread
This project builds a tiny 3D device that measures how solid tumors push, deform, and let cancer cells break away, which could help people with cancers that form solid tumors.
-
Dual-target CAR T therapy with PET tracking for solid tumors
A controllable CAR T-cell treatment that doctors can track with PET scans and direct at solid tumors in adults whose cancers express folate receptors.
-
Atlas of the tumor environment in childhood cancers
This project will map the cells and signals surrounding childhood solid tumors like neuroblastoma, rhabdomyosarcoma, and Wilms tumor to find weaknesses that could help children with high-risk disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.